CG vs IVZ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 03, 2026

CG

41.3
AI Score
VS
IVZ Wins

IVZ

67.3
AI Score

Investment Advisor Scores

CG

41score
Recommendation
HOLD

IVZ

67score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CG IVZ Winner
Forward P/E 7.6805 8.6207 CG
PEG Ratio 0.6555 0.9008 CG
Revenue Growth -32.9% 14.2% IVZ
Earnings Growth -57.5% -1.5% IVZ
Tradestie Score 41.3/100 67.3/100 IVZ
Profit Margin 13.0% -1.1% CG
Beta 1.00 1.00 Tie
AI Recommendation HOLD STRONG BUY IVZ

Relative Price Performance (Last 90 Days)

CG 1M: +10.4% · 3M: -20.0% IVZ 1M: -1.0% · 3M: -11.5%

Current Technical Phase

CG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 54.0 · Price: $41.12

IVZ

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.6 · Price: $28.63

Fundamentals Snapshot

Metric CG IVZ
Market Cap — —
Forward P/E 8.5 8.7
Trailing P/E 43.9 —
Revenue (TTM) — —
Revenue Growth -0.2% 0.1%
Gross Margin 1.0% 0.3%
Operating Margin -0.5% 0.2%
EPS 0.95 -0.69
Dividend Yield 0.03% 0.03%

Frequently Asked Questions

Based on our detailed analysis, IVZ is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.